Roche Under Fire Over ‘Unaffordable’ COVID-19 Therapy Actemra

The WHO Calls For Lower Prices

 
• By Andrew McConaghie
  
Peru COVID-19 ward
Honorio Delgado Hospital in Arequipa, Peru: access to Roche's Actemra is limited in many developing nations. • Source: Getty Images

More from Business

More from Scrip